NCT04398914 2022-03-31Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast CancerShanghai Jiao Tong University School of MedicinePhase 2 Active not recruiting216 enrolled